11 min listen
ACCEL Lite: ESC Congress 2021 Late Breaker: IAMI
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: ESC Congress 2021 Late Breaker: IAMI
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
10 minutes
Released:
Sep 7, 2021
Format:
Podcast episode
Description
In this interview, Laxmi Mehta, MD, FACC, and Ole Frobert, MD, PhD, and discuss the ESC Congress 2021 late breaker IAMI. This study evaluates whether influenza vaccination improves outcomes in patients with recent MI. Influenza vaccine reduced the risk of the primary composite endpoint of all-cause death, MI, and stent thrombosis. Influenza vaccine also reduced two of the three key secondary endpoints. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.
Released:
Sep 7, 2021
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: STRENGTH Trial: High-Dose Omega-3 Fatty Acids vs. Corn Oil: The benefits and risks of fish oil derivatives remain controversial. STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) showed no benefits from administration... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research